Leaflet OSIGRAFT 3.5mg powder for suspension for implantation

Product code:
W51631001
Quantity:
1
Indicated for:
bone disorders
Route of administration:
implantation
Substance:
eptotermin alfa (growth hormone)
ATC
M05BC02 — Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bone morphogenetic proteins

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Eptotermin alfa is a biological medication used for the treatment of malignant pleural effusion, an accumulation of fluid in the pleural cavity caused by cancer. It works by stimulating a controlled inflammatory reaction, which causes the pleural layers to adhere and prevents the recurrence of fluid accumulation.

Eptotermin alfa is administered by direct instillation into the pleural cavity under specialized medical supervision, usually in a hospital. The dose and frequency of treatment are determined individually, depending on the patient's response.

Side effects may include fever, chest pain, local reactions, or, rarely, severe allergic reactions. Careful monitoring is necessary throughout the procedure.

Eptotermin alfa is an effective option for managing malignant pleural effusion, helping to reduce symptoms and improve the quality of life for patients with advanced oncological conditions.

General data about OSIGRAFT 3.5mg

Substance:
eptotermin alfa
Date of latest medicines list:
01-07-2013
Product code:
W51631001
Concentration:
3.5mg
Pharmaceutical form:
powder for suspension for implantation
Quantity:
1
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.